Growth of New Jersey MCL Makes Talcum Powder Cancer Lawsuit News
The multicounty litigation underway in New Jersey, which was in talcum powder ovarian cancer news for its November consolidation, has grown from its initial size of 103 actions to 130 lawsuits as of the latest case filing.
Friday, February 17, 2016 - The multicounty talcum powder litigation in New Jersey, which made talcum powder cancer lawsuit news with the consolidation of 103 lawsuits in November, has since grown to 130 lawsuits as of the court’s latest case list posting on January 23. The lawsuits, which in this case are filed in main defendant Johnson & Johnson’s (J&J) home state, allege that the health care company was aware of research demonstrating a significant link between talcum powder and ovarian cancer and decided against warning consumers of the connection to protect the marketability of their products. J&J has claimed that it has relied on talcum research it has discovered that finds no significant link between talcum powder and ovarian cancer.
The growth in the multicounty litigation lawsuits since the consolidation indicates that talcum powder ovarian cancer lawsuit news has been spreading around the state and raising awareness of the issue for many of the potentially affected women. A Harvard doctor who conducted research into the cancerous tissue of a woman that filed suit against J&J claimed that as many as 10,000 ovarian cancer diagnoses a year could potentially be related to the regular genital use of talcum powder. Given the popularity of J&J’s talcum powder products, which the company has previously recommended to be used daily, the number of lawsuits in multicounty litigation is expected to continue to grow.
The consolidation of the lawsuits in New Jersey was supported by both the plaintiffs and defendants who agreed that centralizing the cases before a single state judge would allow for expedited proceedings. There were already 87 talcum powder lawsuits in the district of the Atlantic City Superior Court, where the lawsuits were eventually consolidated. The plaintiffs had requested for the lawsuits to be consolidated to the Middlesex County Court, claiming that that venue offered the best geographical convenience for the lawsuits. The New Jersey Supreme Court however elected to send the multicounty litigation to Atlantic City where most of the lawsuits were already filed.
The plaintiffs in the lawsuits claim that numerous scientific studies have concluded that the regular genital use of talcum powder is linked to an increased risk for ovarian cancer. A number of studies have inspected women who contracted ovarian cancer and used talcum powder regularly and discovered talc particles lodged in the cancerous tissues. Research studying this link has been taking place since the British medical journal British Journal of Obstetrics and Gynaecology made talcum powder ovarian cancer lawsuit news by publishing the first study suggesting a significant link between talcum powder and ovarian cancer.
Since then, more than 20 research studies have concluded that there is a substantial link between talcum powder and ovarian cancer, with some estimates claiming that regular talcum powder use increases the risk for ovarian cancer by 35 percent. The plaintiffs are bringing these studies as evidence against J&J in the multicounty litigation that will continue to advance through pretrial proceedings in early 2016. Prospective talcum powder plaintiffs in New Jersey will likely keep an eye out for talcum powder cancer lawsuit news to inform their decisions on whether they should file suit against J&J and join the multicounty litigation.
No-Cost, No-Obligation Baby Powder Cancer Lawsuit Case Review for Women and Families of Women Who Were Diagnosed with Ovarian Cancer and Have a History of Using Talcum Powder
The Onder Law Firm
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit Talcum Powder Cancer Lawsuit Center or call 1-877-ONDER-LAW.